The Egyptian Financial Supervisory Authority (EFSA) said it is about to study the offer submitted by Dutch drugs firm Trekwerk BV to buy 46.71% of Minapharm Pharmaceuticals.
The market regulator said the Dutch firm aims to buy 5742679 shares of the Egyptian pharmaceutical producer at EGP 37.5 each.
Minapharm earlier announced that it had received a letter from Trekwerk BV for a potential takeover of up to 100% in the company’s capital.
Minapharm is capitalized at EGP 123.7 million, divided into 12.4 million shares at EGP 10 par value each.
Photo Credit: Arabianeye-Reuters